Products

BraveCX
Bering Limited
Radiology & Imaging AI
BraveCX by Bering Limited is an FDA-cleared AI-powered chest X-ray triage solution that analyzes adult CXR images for pleural effusion and pneumothorax, optimizing radiologist workflow and reducing time-to-diagnosis in emergency settings.

See all 1 product →

About Bering

Bering is a medical AI software company dedicated to developing advanced Clinical Decision Support (CDS) systems that span the entire continuum of health and care. The company is recognized internationally for its state-of-the-art research in machine learning and its practical application to translational medicine. Bering’s core philosophy revolves around creating user-driven products that “listen” to their end-users, fostering shared ownership and ensuring their solutions are effectively utilized and valued by healthcare teams.

Their product portfolio includes innovative AI-augmented platforms designed to address critical needs in healthcare. For instance, Brave AI is a Population Health Management (PHM) platform that integrates and analyzes routinely collected health and social care data to empower organizations in planning proactive anticipatory care. Other offerings include BraveCX, a comprehensive clinical decision support system for the triage of frontal Chest X-Rays, and Brave NGT, a clinical decision support tool for detecting NG tube malposition.

Bering is committed to pushing the technical boundaries of machine learning through collaborations with academic institutions worldwide. They also emphasize examining the ethical implications of mission-critical AI applications, ensuring the development of useful and safe AI technologies across multiple healthcare domains. Beyond direct clinical applications, Bering also applies its expertise to the pharmaceutical industry, aiding in areas such as accelerating drug discovery and enhancing the analysis of clinical trial data.

Focus Areas

Medical Imaging Clinical Decision Support Population Health Management Precision Medicine

Business Intelligence

Key InvestorsInnovate UK, Naxicap Partners
PartnershipsNHS Grampian, Opportunity North East
TechnologyCloud-based service, on-premises deployment, integration with CXR hardware systems, advanced Machine Learning models, in-house scalable Machine Learning Launchpad
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Medical Imaging
Bering offers advanced AI solutions for medical imaging, exemplified by their BraveCX Triage tool. This system utilizes Deep Learning to optimize radiologist workflows by detecting the likelihood of abnormal findings on Chest X-Rays, allowing for prioritized review. BraveCX Triage is FDA 510(k) Cleared and has been trained on over 1,000,000 Chest X-Rays, providing comprehensive abnormality detection. This technology aims to deliver faster and more accurate diagnoses, potentially matching or exceeding human radiologist accuracy rates.
Clinical Decision Support
Bering specializes in Clinical Decision Support (CDS) with tools like Brave NGT, designed for detecting NG Tube malposition. Their AI-enabled CDS systems are built to augment clinician expertise by offering real-time recommendations based on clinical guidelines and data-driven insights. This approach helps healthcare professionals make more accurate diagnoses, predict patient outcomes, and develop personalized treatment plans, thereby reducing the likelihood of medical errors.
Population Health Management
Bering's Brave AI platform is an AI-augmented solution for Population Health Management (PHM). It leverages Machine Learning to integrate and rapidly analyze routinely-collected health and social care data. This enables healthcare organizations to proactively plan anticipatory care by tracking a 12-month risk of unplanned hospital admissions and anticipating demand on Primary Care for each patient. Brave AI's advanced case-finding algorithms support risk stratification and efficient resource allocation.
Precision Medicine
Bering is active in Precision Medicine, a field focused on tailoring treatments to individual patient characteristics, including genetic predisposition, molecular makeup, lifestyle, and environmental factors. This approach aims to improve patient outcomes by matching individuals with the most effective treatments, reducing side effects, and lowering healthcare costs by avoiding unnecessary interventions. Bering's involvement signifies their application of 'big data' molecular biology and computational tools in clinical contexts.
Key Differentiators
Bering stands out through its user-driven co-design process, ensuring products are developed with direct input from end-users to foster adoption and satisfaction. Their foundation lies in advanced Machine Learning models, delivering high accuracy and health-economic value. A strong commitment to R&D and ethical AI application, in collaboration with academic institutions, ensures the development of useful and safe mission-critical AI. Furthermore, their in-house scalable ML Ops Launchpad allows for flexible deployment and monitoring of AI services across various environments. The FDA 510(k) clearance for BraveCX Triage highlights their commitment to regulatory standards.
Technology Stack
Bering's core technology stack is built upon Artificial Intelligence (AI) and Machine Learning (ML). They specifically utilize Deep Learning for tasks like radiological sign identification in BraveCX Triage. A key component is their in-house scalable Machine Learning Operations (ML Ops) Launchpad, which facilitates the orchestration, deployment, and monitoring of their AI services across personal devices, on-premise infrastructure, or cloud environments. Their platforms are designed for robust data integration and rapid analysis of health and social care data.
Physician Tip

For physicians, Bering's solutions are designed to **augment clinical expertise**, not replace it. Their AI tools provide data-driven insights, probability estimates, and real-time recommendations to inform clinical judgment, leading to more confident and faster decision-making. Expect improved diagnostic accuracy and workflow efficiency, particularly in medical imaging where tools can prioritize urgent cases and enhance interpretation. The Population Health Management platform enables **proactive patient care** by identifying at-risk individuals, allowing for earlier interventions and optimized resource allocation. In Precision Medicine, the focus is on providing insights for **tailored treatments**, aiming for better patient outcomes and reduced side effects. Bering's emphasis on a user-driven co-design process suggests that their tools are built with physician workflows in mind, potentially reducing administrative burdens and improving overall usability. Their commitment to ethical and safe AI development fosters trust and reliability in their technologies.

Bering's AI platforms are likely designed for integration with existing healthcare IT infrastructure, including Electronic Health Record (EHR) systems. Seamless integration is crucial for the effective push and pull of information, enabling real-time insights within clinical workflows. While specific integration partners are not detailed, the broader trend in healthcare AI emphasizes native EMR integration as a key differentiator for seamless data flow and interoperability.

Products by Bering

1 product in the directory

BraveCX
Bering Limited
Radiology & Imaging AI
BraveCX by Bering Limited is an FDA-cleared AI-powered chest X-ray triage solution that analyzes adult CXR images for pleural effusion and pneumothorax, optimizing radiologist workflow and reducing time-to-diagnosis in emergency settings.

Reviews & Opinions

No web reviews on file yet for Bering. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Bering.

Loading videos...

Videos load interactively. If none appear, search YouTube for Bering →

View all on YouTube

Press & Coverage

Bering Limited
Bering Secures FDA Clearance for AI-Based Chest X-Ray Triage Solution
Bering Limited, a London-based company, received FDA 510(k) clearance for its AI Radiology software product designed for triaging emergency cases found on chest X-rays. This clearance is expected to accelerate their business in the US market through new and existing partnerships.
2023-12
Slator
Language AI Agency Bering Lab Raises USD 2.3M in Pre-Series A
South Korea-headquartered Bering Lab, a legal AI translation startup, raised USD 2.3 million in a pre-Series A funding round, led by SoftBank Ventures Asia. The company, founded in 2020, aims to expand its geographical reach and expertise in legal, financial, and intellectual property content.
2024-08
Startup Intros
Bering Lab - $2.2M Seed Stage Venture | Startup Intros
Bering Lab successfully completed a $2.2 million Seed Plus venture round, with SoftBank Ventures Asia as the lead investor. This funding contributes to the company's total of $2.18 million raised over two seed funding rounds.
2024-08
Superyachts.com
Milestone Construction Updates and Exciting New Launches from Bering Yachts
Bering Yachts announced new developments, including the transportation of Bering 125 to Antalya and the launch of three new vessels: Bering 121, Bering 80, and Bering 65. These releases highlight the Turkish shipyard's dedication to innovation and craftsmanship in luxury yacht building.
2024-07
DigitalSurf News
Barings Emerging EMEA Opportunities Plc - Compliance with Market Abuse Regulation
Barings Emerging EMEA Opportunities PLC announced it would enter a closed period on May 8, 2024, in relation to its half-year results. The company, a UK-based investment trust, focuses on growth and income from quality companies in the Emerging Europe, Middle East, and Africa region.
2024-05
Regenerative Biomaterials (Oxford Academic)
Magnesium as an emerging bioactive material for orthopedic applications: bedside needs lead the way from innovation to clinical translation
This peer-reviewed article discusses magnesium as a bioactive material for orthopedic applications, driven by the increasing number of surgical operations due to population aging. It explores the challenges and future directions of magnesium-based medical implants for clinical translation.
2025-04
Bering Yachts
Bering 121 Familia: Statement from Bering Yachts
Bering Yachts issued a statement regarding an incident involving the yacht Familia in Sinop, Tu00fcrkiye, expressing concern for those affected and relief that all crew members were safe. The yacht, delivered in January 2025, underwent a major third-party modification in 2026, which included extending the hull.
2026-06
Bering Yachts
Bering 110: Coming Soon
Bering Yachts announced the upcoming introduction of the Bering 110, a new superyacht that will redefine luxury and exploration. This model features a fresh exterior design and a blend of comfort, ergonomics, and the Bering Yachts DNA.
2025-09

Frequently Asked Questions

Bering offers BraveCX Triage for medical imaging, an AI-powered chest X-ray triage software that detects and prioritizes emergency findings like pleural effusion and pneumothorax. For clinical decision support, they provide Brave NGT, a tool designed to assist in detecting nasogastric tube malposition.
Brave AI is a Population Health Management (PHM) platform that uses machine learning to analyze routinely collected health and social care data in real-time. It predicts a patient's risk of unplanned hospital admission and anticipated demand on primary care, enabling proactive interventions and personalized care plans. Pilots have shown significant reductions in emergency department attendances and resident falls.
Bering Limited's BraveCX AI-powered chest X-ray triage software received U.S. Food and Drug Administration (FDA) 510(k) clearance in December 2023. This clearance allows the company to commercially provide this AI solution to medical professionals and healthcare institutions in the U.S., demonstrating adherence to regulatory standards for safety and efficacy.
Bering emphasizes creating useful and safe AI technologies, including examining the ethics of mission-critical AI applications. For its Brave AI platform, patient data remains confidential and is not directly shared with Bering Ltd., with the tool only being used by approved practice staff and healthcare professionals in a safe clinical environment.
For the Brave AI Population Health Management platform, pricing involves an initial implementation fee, typically u00a310-12,000 per instance, and an annual subscription ranging from u00a35-25,000 per instance, covering 2,000 to 50,000 citizens. Bering offers flexible deployment models for its products, including cloud-based services, on-premises installation, or integration with existing hardware systems.
Bering employs a user-driven co-design process for product development and collaborates with academic institutions for research and development. They also leverage partnerships for market expansion, and their Brave AI platform has been supported and rolled out by entities like Health Innovation South West and NHS Somerset, indicating strong local implementation support.
Bering Limited is a London-based medical AI company with a decade of successful adoption and spread of its Brave AI platform in the UK, demonstrating sustained market presence and positive impact. The recent FDA clearance for BraveCX further solidifies its position for expansion into the U.S. market, supported by reinvestment of revenues into R&D and evaluation.

Investors

Who's funded Bering.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.